The Institute of Neuroscience organised “Strokekathon” - an awareness-driven event with a special focus on brain stroke, its prevention and its line of treatment. The event was conducted on 27th November 2022 at the Helipad area, Indraprastha Apollo Hospitals, New Delhi. Contributing to this initiative Apollo
Epilepsy is one of the most common neurological disorders affecting about 60 lakh people in India. In 70 % of these patients, seizures can be controlled with medical treatment. However, 30 % of patients, (approximately 16 lakh patients in India), have drug-resistant epilepsy which is
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD Indicated in adults for the treatment of patients of Chronic Kidney Disease up to eGFR greater than or equal to 25 ml per min per 1.73 m2 AstraZeneca
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
